Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Higher testosterone harms sperm motility, while higher estradiol improves sperm survival.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Some skin diseases and their treatments can negatively affect male fertility.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

COVID-19 may harm male fertility and damage the reproductive system.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Some common medications can harm male fertility, but many effects can be reversed.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

5-Aminolevulinic acid can help chicken sperm move better at the right amount.